Biofarm Ends Jan-Sept 2024 Period With RON73M Net Profit And RON231M Sales
Nov 14, 2024
Biofarm Ends Jan-Sept 2024 Period With RON73M Net Profit And RON231M Sales.
Pharmaceutical producer Biofarm Bucuresti (stock symbol: BIO) ended the first nine months of 2024 with net profit of RON73.25 million, at an individual level, up 4.7% from the same period of 2023, as per its quarterly financial report published at the Bucharest Stock Exchange on Nov 14.
[Read the article in Ziarul Financiar]